Precision Medicine Market Size, Trends, Analysis, and Outlook By Type (Inhibitor drugs, Monoclonal Antibodies, Cell & Gene Therapy, Antiviral & Anti-retroviral drugs, Others), By Indication (Oncology, Rare Diseases, Infectious diseases, Hematological disorders, Others), By End-User (Hospitals and Clinics, Home care settings), by Country, Segment, and Companies, 2024-2032
The global Precision Medicine market size is poised to register 12.3% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Precision Medicine market across By Type (Inhibitor drugs, Monoclonal Antibodies, Cell & Gene Therapy, Antiviral & Anti-retroviral drugs, Others), By Indication (Oncology, Rare Diseases, Infectious diseases, Hematological disorders, Others), By End-User (Hospitals and Clinics, Home care settings)
The future of the precision medicine market is influenced by advancements in genomics, proteomics, and digital health technologies, increasing adoption of personalized therapies, and growing emphasis on genomic-driven drug development and targeted cancer treatments. Precision medicine, also known as personalized medicine, is a medical approach that leverages genetic and molecular information to tailor medical treatments and interventions to the individual characteristics of each patient, including their genetic makeup, biomarker profiles, and environmental factors, to optimize therapeutic efficacy, minimize adverse effects, and improve patient outcomes. With the rise of precision oncology, rare disease diagnostics, and pharmacogenomics, there is a growing need for precision medicine solutions that offer comprehensive genomic profiling, data interpretation, and clinical decision support to guide treatment selection, drug dosing, and patient management across diverse disease areas and healthcare settings. Further, technological innovations such as next-generation sequencing (NGS), liquid biopsy assays, and bioinformatics algorithms are driving the development of next-generation precision medicine platforms with improved accuracy, sensitivity, and scalability for biomarker discovery, patient stratification, and targeted therapy development. Over the forecast period to 2030, expanding applications in cancer immunotherapy, molecular diagnostics, and companion diagnostics, coupled with increasing investments in precision medicine research and infrastructure, are expected to drive market growth and innovation, enabling healthcare providers, pharmaceutical companies, and diagnostic laboratories to advance the field of precision medicine and deliver more personalized, effective, and affordable healthcare solutions to patients worldwide.
Precision Medicine Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Precision Medicine market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Precision Medicine survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Precision Medicine industry.
Key market trends defining the global Precision Medicine demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Precision Medicine Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The Precision Medicine industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Precision Medicine companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Precision Medicine industry
Leading Precision Medicine companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Precision Medicine companies.
Precision Medicine Market Study- Strategic Analysis Review
The Precision Medicine market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Precision Medicine industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
Precision Medicine Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America Precision Medicine Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Precision Medicine market segments. Similarly, Strong market demand is encouraging Canadian Precision Medicine companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Precision Medicine market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Precision Medicine Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Precision Medicine industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Precision Medicine market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Precision Medicine Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Precision Medicine in Asia Pacific. In particular, China, India, and South East Asian Precision Medicine markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America Precision Medicine Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Precision Medicine Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Precision Medicine market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Precision Medicine.
Precision Medicine Market Company Profiles
The global Precision Medicine market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are AbbVie Inc, Amgen Inc, AstraZeneca PLC, Bristol Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Gilead Sciences Inc, GlaxoSmithKline plc, Johnson & Johnson, Merck KGaA, Novartis AG, Pfizer Inc, Sanofi SA.
Recent Precision Medicine Market Developments
The global Precision Medicine market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Precision Medicine Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Type
Inhibitor drugs
Monoclonal Antibodies
Cell & Gene Therapy
Antiviral & Anti-retroviral drugs
Others
By Indication
Oncology
Rare Diseases
Infectious diseases
Hematological disorders
Others
By End-User
Hospitals and Clinics
Home care settings
Geographical Segmentation:
AbbVie Inc
Amgen Inc
AstraZeneca PLC
Bristol Myers Squibb Company
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
Gilead Sciences Inc
GlaxoSmithKline plc
Johnson & Johnson
Merck KGaA
Novartis AG
Pfizer Inc
Sanofi SA
Formats Available: Excel, PDF, and PPT
The future of the precision medicine market is influenced by advancements in genomics, proteomics, and digital health technologies, increasing adoption of personalized therapies, and growing emphasis on genomic-driven drug development and targeted cancer treatments. Precision medicine, also known as personalized medicine, is a medical approach that leverages genetic and molecular information to tailor medical treatments and interventions to the individual characteristics of each patient, including their genetic makeup, biomarker profiles, and environmental factors, to optimize therapeutic efficacy, minimize adverse effects, and improve patient outcomes. With the rise of precision oncology, rare disease diagnostics, and pharmacogenomics, there is a growing need for precision medicine solutions that offer comprehensive genomic profiling, data interpretation, and clinical decision support to guide treatment selection, drug dosing, and patient management across diverse disease areas and healthcare settings. Further, technological innovations such as next-generation sequencing (NGS), liquid biopsy assays, and bioinformatics algorithms are driving the development of next-generation precision medicine platforms with improved accuracy, sensitivity, and scalability for biomarker discovery, patient stratification, and targeted therapy development. Over the forecast period to 2030, expanding applications in cancer immunotherapy, molecular diagnostics, and companion diagnostics, coupled with increasing investments in precision medicine research and infrastructure, are expected to drive market growth and innovation, enabling healthcare providers, pharmaceutical companies, and diagnostic laboratories to advance the field of precision medicine and deliver more personalized, effective, and affordable healthcare solutions to patients worldwide.
Precision Medicine Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Precision Medicine market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Precision Medicine survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Precision Medicine industry.
Key market trends defining the global Precision Medicine demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Precision Medicine Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The Precision Medicine industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Precision Medicine companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Precision Medicine industry
Leading Precision Medicine companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Precision Medicine companies.
Precision Medicine Market Study- Strategic Analysis Review
The Precision Medicine market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Precision Medicine industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
Precision Medicine Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America Precision Medicine Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Precision Medicine market segments. Similarly, Strong market demand is encouraging Canadian Precision Medicine companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Precision Medicine market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Precision Medicine Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Precision Medicine industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Precision Medicine market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Precision Medicine Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Precision Medicine in Asia Pacific. In particular, China, India, and South East Asian Precision Medicine markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America Precision Medicine Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Precision Medicine Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Precision Medicine market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Precision Medicine.
Precision Medicine Market Company Profiles
The global Precision Medicine market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are AbbVie Inc, Amgen Inc, AstraZeneca PLC, Bristol Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Gilead Sciences Inc, GlaxoSmithKline plc, Johnson & Johnson, Merck KGaA, Novartis AG, Pfizer Inc, Sanofi SA.
Recent Precision Medicine Market Developments
The global Precision Medicine market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Precision Medicine Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Type
Inhibitor drugs
Monoclonal Antibodies
Cell & Gene Therapy
Antiviral & Anti-retroviral drugs
Others
By Indication
Oncology
Rare Diseases
Infectious diseases
Hematological disorders
Others
By End-User
Hospitals and Clinics
Home care settings
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
AbbVie Inc
Amgen Inc
AstraZeneca PLC
Bristol Myers Squibb Company
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
Gilead Sciences Inc
GlaxoSmithKline plc
Johnson & Johnson
Merck KGaA
Novartis AG
Pfizer Inc
Sanofi SA
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Precision Medicine Market Overview and Key Findings, 2024
1.2 Precision Medicine Market Size and Growth Outlook, 2021- 2030
1.3 Precision Medicine Market Growth Opportunities to 2030
1.4 Key Precision Medicine Market Trends and Challenges
1.4.1 Precision Medicine Market Drivers and Trends
1.4.2 Precision Medicine Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Precision Medicine Companies
2. PRECISION MEDICINE MARKET SIZE OUTLOOK TO 2030
2.1 Precision Medicine Market Size Outlook, USD Million, 2021- 2030
2.2 Precision Medicine Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. PRECISION MEDICINE MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. PRECISION MEDICINE MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Type
Inhibitor drugs
Monoclonal Antibodies
Cell & Gene Therapy
Antiviral & Anti-retroviral drugs
Others
By Indication
Oncology
Rare Diseases
Infectious diseases
Hematological disorders
Others
By End-User
Hospitals and Clinics
Home care settings
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Precision Medicine Market, 2025
5.2 Asia Pacific Precision Medicine Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Precision Medicine Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Precision Medicine Market, 2025
5.5 Europe Precision Medicine Market Size Outlook by Type, 2021- 2030
5.6 Europe Precision Medicine Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Precision Medicine Market, 2025
5.8 North America Precision Medicine Market Size Outlook by Type, 2021- 2030
5.9 North America Precision Medicine Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Precision Medicine Market, 2025
5.11 South America Pacific Precision Medicine Market Size Outlook by Type, 2021- 2030
5.12 South America Precision Medicine Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Precision Medicine Market, 2025
5.14 Middle East Africa Precision Medicine Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Precision Medicine Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Precision Medicine Market Size Outlook and Revenue Growth Forecasts
6.2 US Precision Medicine Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Precision Medicine Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Precision Medicine Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Precision Medicine Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Precision Medicine Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Precision Medicine Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Precision Medicine Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Precision Medicine Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Precision Medicine Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Precision Medicine Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Precision Medicine Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Precision Medicine Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Precision Medicine Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Precision Medicine Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Precision Medicine Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Precision Medicine Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Precision Medicine Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Precision Medicine Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Precision Medicine Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Precision Medicine Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Precision Medicine Industry Drivers and Opportunities
7. PRECISION MEDICINE MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. PRECISION MEDICINE COMPANY PROFILES
8.1 Profiles of Leading Precision Medicine Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
AbbVie Inc
Amgen Inc
AstraZeneca PLC
Bristol Myers Squibb Company
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
Gilead Sciences Inc
GlaxoSmithKline plc
Johnson & Johnson
Merck KGaA
Novartis AG
Pfizer Inc
Sanofi SA.
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Precision Medicine Market Overview and Key Findings, 2024
1.2 Precision Medicine Market Size and Growth Outlook, 2021- 2030
1.3 Precision Medicine Market Growth Opportunities to 2030
1.4 Key Precision Medicine Market Trends and Challenges
1.4.1 Precision Medicine Market Drivers and Trends
1.4.2 Precision Medicine Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Precision Medicine Companies
2. PRECISION MEDICINE MARKET SIZE OUTLOOK TO 2030
2.1 Precision Medicine Market Size Outlook, USD Million, 2021- 2030
2.2 Precision Medicine Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. PRECISION MEDICINE MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. PRECISION MEDICINE MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Type
Inhibitor drugs
Monoclonal Antibodies
Cell & Gene Therapy
Antiviral & Anti-retroviral drugs
Others
By Indication
Oncology
Rare Diseases
Infectious diseases
Hematological disorders
Others
By End-User
Hospitals and Clinics
Home care settings
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Precision Medicine Market, 2025
5.2 Asia Pacific Precision Medicine Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Precision Medicine Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Precision Medicine Market, 2025
5.5 Europe Precision Medicine Market Size Outlook by Type, 2021- 2030
5.6 Europe Precision Medicine Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Precision Medicine Market, 2025
5.8 North America Precision Medicine Market Size Outlook by Type, 2021- 2030
5.9 North America Precision Medicine Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Precision Medicine Market, 2025
5.11 South America Pacific Precision Medicine Market Size Outlook by Type, 2021- 2030
5.12 South America Precision Medicine Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Precision Medicine Market, 2025
5.14 Middle East Africa Precision Medicine Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Precision Medicine Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Precision Medicine Market Size Outlook and Revenue Growth Forecasts
6.2 US Precision Medicine Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Precision Medicine Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Precision Medicine Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Precision Medicine Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Precision Medicine Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Precision Medicine Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Precision Medicine Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Precision Medicine Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Precision Medicine Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Precision Medicine Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Precision Medicine Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Precision Medicine Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Precision Medicine Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Precision Medicine Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Precision Medicine Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Precision Medicine Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Precision Medicine Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Precision Medicine Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Precision Medicine Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Precision Medicine Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Precision Medicine Industry Drivers and Opportunities
7. PRECISION MEDICINE MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. PRECISION MEDICINE COMPANY PROFILES
8.1 Profiles of Leading Precision Medicine Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
AbbVie Inc
Amgen Inc
AstraZeneca PLC
Bristol Myers Squibb Company
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
Gilead Sciences Inc
GlaxoSmithKline plc
Johnson & Johnson
Merck KGaA
Novartis AG
Pfizer Inc
Sanofi SA.
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
